Forbes -- Drugmaker Sanofi-Aventis SA said net profit rose 61 percent to euro1.7 billion ($2.2 billion) in the second quarter, thanks to lower restructuring costs, but warned that earnings may fall for the full year.
Forbes -- Drugmaker Sanofi-Aventis SA said net profit rose 61 percent to euro1.7 billion ($2.2 billion) in the second quarter, thanks to lower restructuring costs, but warned that earnings may fall for the full year.
